Maya Sasson

About the Author Maya Sasson

Maya Sasson, originally from San Francisco, California, is a financial writer focusing on U.S. stocks as well as analyst activity. Before diving into the world of financial writing, she earned a B.S. in Mathematics from Tufts University, and began her career as a data analyst for a software company.

Stay Hale and Hearty: 3 Healthcare Stocks to Buy Right Now

It was a rough start to the week, to put it lightly. As oil prices continued to slide yesterday, the S&P 500 suffered …

Goldman Sachs Sees Doom and Gloom in These 3 Tech Stock Giants

Wall Street observers hoped last week’s gains signaled the arrival of blue skies, but the COVID-19 storm is thundering on. Stocks started the …

With FDA Approvals in Hand, These 2 Biotech Stocks Are on Wall Street’s Radar

And we have a winner. After a long and arduous development process, only a few biotech names will emerge having attained the ultimate …

Billionaire Steven Cohen Snaps up These 2 Stocks as Markets Rebound

Are the dark clouds that have been looming over Wall Street finally dissipating? The recent rally in stocks has generated hope among some …

3 “Strong Buy” Biotech Stocks with FDA Approvals on the Horizon

COVID-19 has turned the world upside down, but the market’s most recent surge has Wall Street observers wondering if the situation is on the mend. Rallying on April 17 thanks to encouraging data from Gilead’s remdesivir COVID-19 drug …

Jefferies Pounds the Table on Aphria (APHA) Stock

The results are in, and it looks like cannabis company Aphria (APHA) hit another ball out of the park. Unlike other heavy hitters …

Moderna’s COVID-19 Vaccine Potential Taking Shape

COVID-19 has put the world in a chokehold, but one biotech name appears to be well on its way to delivering a match-winning …

3 Compelling Penny Stocks With at Least 50% Upside Potential

Dark clouds are looming over Wall Street, and the storm only appears to be intensifying. The market was dealt another blow on Wednesday …

Can Aridis Pharmaceuticals’ APEX Platform Be Used to Target Coronavirus? Analyst Weighs In

If nothing else, the COVID-19 pandemic has spurred vast cooperation in the healthcare space. Having said that, it remains unclear as to what …

Billionaire David Shaw Pulls the Trigger on These 2 Stocks

Earnings season kicks off this week, and market watchers are preparing for the worst. The upcoming release of first quarter financial results is …

Stay Ahead of Everyone Else

Get The Latest Stock News Alerts